Skip to main content

Advertisement

Log in

Recent advances of nanotechnology for the delivery of anticancer drugs for breast cancer treatment

  • Review
  • Published:
Journal of Pharmaceutical Investigation Aims and scope Submit manuscript

Abstract

Background

Breast cancer is one of the most common causes of death for women worldwide. While chemotherapy is the treatment option for most cancers, surgery, chemotherapy, and radiotherapy are the three main therapeutic strategies for the treatment of breast cancer. In recent years, nanotechnology applications for cancer treatments have attracted a lot of attention.

Area covered

This review focuses on the various nanoparticle types, such as liposomes, micelles, polymeric nanoparticles, solid lipid nanoparticles, and gold nanoparticles, and their applications for the treatment of breast cancer.

Expert opinion

In recent decades, nanotechnology has developed and been applied to cancer treatments. Currently, nanotechnology plays an important role in the targeted delivery of drugs for cancer treatments, including breast cancer. Nanoparticles can target tumors and control the release of drugs to precise sites, thereby improving the therapeutic efficiency of drugs and decreasing the toxicity to normal tissues or organs. In addition, nanoparticles are also able to activate immune cells against tumors. Therefore, nanoparticles are a promising tool for future cancer research and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

Download references

Acknowledgements

This work was supported by research fund of Chungnam National University in 2018.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jeong-Sook Park.

Ethics declarations

Conflict of interest

All authors declare that they have no conflict of interest.

Research involving human and animal rights

This review does not contain any studies with human and animal subjects performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tran, P., Lee, SE., Kim, DH. et al. Recent advances of nanotechnology for the delivery of anticancer drugs for breast cancer treatment. J. Pharm. Investig. 50, 261–270 (2020). https://doi.org/10.1007/s40005-019-00459-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40005-019-00459-7

Keywords

Navigation